These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33292227)

  • 21. Correction to: The role of microRNA-133b and its target gene FSCN1 in gastric cancer.
    Guo L; Bai H; Zou D; Hong T; Liu J; Huang J; He P; Zhou Q; He J
    J Exp Clin Cancer Res; 2020 Oct; 39(1):220. PubMed ID: 33081806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.
    Xu K; Park D; Magis AT; Zhang J; Zhou W; Sica GL; Ramalingam SS; Curran WJ; Deng X
    Mol Cancer; 2020 May; 19(1):93. PubMed ID: 32434536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment.
    Cheng SS; Yang GJ; Wang W; Leung CH; Ma DL
    J Hematol Oncol; 2020 Jul; 13(1):102. PubMed ID: 32709244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction to: Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways.
    Hu Z; Long T; Ma Y; Zhu J; Gao L; Zhong Y; Wang X; Wang X; Li Z
    J Exp Clin Cancer Res; 2020 Jul; 39(1):125. PubMed ID: 32624003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correction to: Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
    Kim H; Heo MH; Kim JY
    BMC Gastroenterol; 2020 Jul; 20(1):207. PubMed ID: 32615928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction to: Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis.
    Fan L; Cao Q; Liu J; Zhang J; Li B
    Mol Cancer; 2020 Jul; 19(1):113. PubMed ID: 32615993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway.
    Zhang J; Liu XH; Li C; Wu XX; Chen YL; Li WW; Li X; Gong F; Tang Q; Jiang D
    J Exp Clin Cancer Res; 2020 Jun; 39(1):115. PubMed ID: 32552756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction to: Early gastric cancer with three gastric gastrointestinal stromal tumors combined with synchronous colon cancer: a case report.
    Lee SC; Nam K; Nam D; Kwon MA; Kim DW
    World J Surg Oncol; 2020 Sep; 18(1):256. PubMed ID: 32998754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex.
    Subramanian N; Kanwar JR; Athalya PK; Janakiraman N; Khetan V; Kanwar RK; Eluchuri S; Krishnakumar S
    J Biomed Sci; 2020 Nov; 27(1):100. PubMed ID: 33161903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction to: A pilot study of improved psychological distress with art therapy in patients with cancer undergoing chemotherapy.
    Elimimian EB; Elson L; Stone E; Butler RS; Doll M; Roshon S; Kondaki C; Padgett A; Nahleh ZA
    BMC Cancer; 2020 Nov; 20(1):1125. PubMed ID: 33218337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correction to: Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancreatic cancer cells.
    Xu Z; Zhang F; Bai C; Yao C; Zhong H; Zou C; Chen X
    J Exp Clin Cancer Res; 2020 Nov; 39(1):263. PubMed ID: 33243299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD).
    Yamashita T; Masuda N; Saji S; Araki K; Ito Y; Takano T; Takahashi M; Tsurutani J; Koizumi K; Kitada M; Kojima Y; Sagara Y; Tada H; Iwasa T; Kadoya T; Iwatani T; Hasegawa H; Morita S; Ohno S
    Trials; 2020 Jun; 21(1):503. PubMed ID: 32513251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction to: Overexpression of SOX4 induces up-regulation of miR-126 and miR-195 in LNCaP prostate cancer cell line.
    Phan NN; Moreno CS; Lai YH
    Cytotechnology; 2020 Aug; 72(4):603. PubMed ID: 32715403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction to: LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
    Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
    J Exp Clin Cancer Res; 2020 Aug; 39(1):155. PubMed ID: 32787877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction to: Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating acrophages with alteration of the TIMP-1/MMP2/MMP9 signals.
    Ding X; Yang DR; Xia L; Chen B; Yu S; Niu Y; Wang M; Li G; Chang C
    Mol Cancer; 2020 May; 19(1):97. PubMed ID: 32473639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction to: Yttrium-90 radioembolization as a possible new treatment for brain cancer: proof of concept and safety analysis in a canine model.
    Pasciak AS; Manupipatpong S; Hui FK; Gainsburg L; Krimins R; Zink MC; Brayton CF; Morris M; Sage J; Donahue DR; Dreher MR; Kraitchman DL; Weiss CR
    EJNMMI Res; 2020 Sep; 10(1):104. PubMed ID: 32910303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction to: CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/MEK1/ERK1/2 signaling.
    Zhang J; Hou L; Liang R; Chen X; Zhang R; Chen W; Zhu J
    Mol Cancer; 2020 Aug; 19(1):125. PubMed ID: 32787855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.
    Ebert K; Zwingenberger G; Barbaria E; Keller S; Heck C; Arnold R; Hollerieth V; Mattes J; Geffers R; Raimúndez E; Hasenauer J; Luber B
    BMC Cancer; 2020 Nov; 20(1):1127. PubMed ID: 33225928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction to: Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
    Mol Cancer; 2020 Aug; 19(1):124. PubMed ID: 32772915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Author Correction: Genomic epidemiology of Mycobacterium tuberculosis in Santa Catarina, Southern Brazil.
    Verza M; Scheffer MC; Salvato RS; Schorner MA; Barazzetti FH; de Melo Machado H; Medeiros TF; Rovaris DB; Portugal I; Viveiros M; Perdigão J; Kritski A; Bazzo ML
    Sci Rep; 2020 Nov; 10(1):19250. PubMed ID: 33139782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.